ArticleJournal of clinical medicine2022

Favorable Humoral Response to Third Dose of BNT162b2 in Patients Undergoing Hemodialysis.

Mineaki Kitamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.